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Abstract
Background: Gene Regulatory Networks (GRNs) have become a major focus of interest in recent years. Elucidating the
architecture and dynamics of large scale gene regulatory networks is an important goal in systems biology. The knowledge
of the gene regulatory networks further gives insights about gene regulatory pathways. This information leads to many
potential applications in medicine and molecular biology, examples of which are identification of metabolic pathways,
complex genetic diseases, drug discovery and toxicology analysis. High-throughput technologies allow studying various
aspects of gene regulatory networks on a genome-wide scale and we will discuss recent advances as well as limitations and
future challenges for gene network modeling. Novel approaches are needed to both infer the causal genes and generate
hypothesis on the underlying regulatory mechanisms.
Methodology: In the present article, we introduce a new method for identifying a set of optimal gene regulatory pathways
by using structural equations as a tool for modeling gene regulatory networks. The method, first of all, generates data on
reaction flows in a pathway. A set of constraints is formulated incorporating weighting coefficients. Finally the gene
regulatory pathways are obtained through optimization of an objective function with respect to these weighting
coefficients. The effectiveness of the present method is successfully tested on ten gene regulatory networks existing in the
literature. A comparative study with the existing extreme pathway analysis also forms a part of this investigation. The results
compare favorably with earlier experimental results. The validated pathways point to a combination of previously
documented and novel findings.
Conclusions: We show that our method can correctly identify the causal genes and effectively output experimentally
verified pathways. The present method has been successful in deriving the optimal regulatory pathways for all the
regulatory networks considered. The biological significance and applicability of the optimal pathways has also been
discussed. Finally the usefulness of the present method on genetic engineering is depicted with an example.
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Introduction
Gene regulatory networks perform fundamental information
processing and control mechanisms in the cell. Regulatory genes
code for proteins that activate or inhibit the expression of other
genes, thereby forming a complex web of interactions. Such
networks perhaps form the most important organizational level in
thecell,wheresignalsfromthecellstateandtheoutsideenvironment
are integrated in terms of activation and inhibition of genes. Genetic
network analysis [1] is expected to help experimental biology in
many ways. Practical applications may have a strong impact on
biotech and pharmaceutical industries, and in genetic engineering,
potentiallysetting thestage for rationalredesign ofliving systems and
predictive model-based drug design [2].
Owing to the high connectivity of the different regulatory
interactions within the gene regulatory network, there has been
considerable interest in exploiting tools from functional genomics
for mapping of global regulatory structures or using high
throughput experimental techniques for determining how regula-
tory flows through different branches of the gene regulatory
network are controlled. Regulatory flows through a given
interaction can be controlled by transcription, translation or
posttranslational modifications, i.e. modification of the active
enzyme concentration. The activity of genes in genomes of higher
eukaryotic organisms is regulated mainly by the means of huge
class of regulatory proteins (transcription factors, TF), through
specific regulatory sequences - TF binding sites that are located
usually in a proximity of the genes.
Pathway analysis is becoming increasingly important for
assessing inherent network properties of biochemical reaction
networks [3,4]. Of the two most promising concepts for pathway
analysis, one relies on elementary flux modes [5] and the other on
extreme pathways. Flux balance analysis (FBA) [6] is based on the
fundamental law of mass conservation and the application of
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12475optimization principles to determine the optimal distribution of
resources within a network. Due to the presence of the inequality
constraints on various fluxes, linear algebra can no longer handle
such a mathematical system of equalities/inequalities, forcing the
use of convex analysis [7,8] to study the properties of the solution
space. The mathematical foundations and unique features of these
pathways enable one to evaluate pathway/network properties such
as product yield, network robustness. Thus elementary modes and
extreme pathways play a growing role in the analysis of complex
biochemical reaction networks [9].
Flux balance analysis (FBA) has been useful for large scale
analysis of metabolic networks, and methods have been developed
to extend this approach for transcriptional regulation [10,11]. Here
we develop a method incorporating the principle of regularization
for identificationof an optimal pathway in gene regulatorynetworks
starting from a given gene to a target gene. The method, first of all,
generates the possible flow vectorsinthepathway. We consider only
those flow vectors which, by taking convex combination of the basis
vectors spanning the null space of the given node-edge incidence
matrix, satisfy the quasi-steady state condition along with other
inequality constraints. Then a set of weighting coefficients
representing concentration of various transcription factors is
incorporated. A set of constraints involving these weighting
coefficients is formulated. An objective function, in terms of these
weighting coefficients, is formed, and then minimized under
regularization method. The weighting coefficients corresponding
to a minimum value of the objective function represent an optimal
pathway. These optimal pathways determine the gene regulatory
routes leading from the transcription of a given gene to the
transcription of another gene, and represent the structural and
functional properties of the network as a whole. The methodology
can be viewed as flow of some information (or some approximation
thereof) in a regulatory network, and an optimal path means the
pathway where disruption has the largest effect. The effectiveness of
the present method is demonstrated on ten gene regulatory
networks. The results are compared with those obtained from the
existing extreme pathway analysis [12,13]. Results have been
validated appropriately from biological point of view.
The exploration of optimal regulatory pathways helps in
understanding the extent of regulatory relationships among the
genes. Through this study, it is possible to compare optimal
regulatory pathways over various stages of development, and a
variety of other cellular phenotypes over diseases [14,15]. Inferring
the genes on the optimal regulatory path is challenging and very
important in disease studies [16]. These regulatory pathways have
been widely found in multiple biological processes and are
considered to be one of the most fundamental gene expression
regulatory mechanisms in biological systems [17]. This method
might be successful in identifying important genes that are
responsible for ceratin diseases [18,19]. Genes on the optimal
regulatory pathway have immediate and widespread interest as
markers for diseases [15]. Precise knowledge of optimal gene
regulatory pathways can provide an understanding of the time-
dependent enhancement and suppression of gene activity and drug
effectiveness [20–22].
Results
Here we demonstrate the effectiveness of the present method
using various gene regulatory networks. For this purpose, we
consider ten gene regulatory networks as shown in Fig. 1 [13],
Fig. 2 [23], Fig. 3 [24], Fig. 4 [25] and Fig. S1 [13], Fig. S2 [26],
Figs. S3, S4, S5 [27] and Fig. S6 [28]. The results have been
compared with that of the existing extreme pathway analysis
[12,13]. Biological validation of the results is also included.
It may be mentioned here that the present method involves a
parameter l, called Lagrange’s multiplier or regularizing param-
eter. We vary the value of l from 0.1 to 1.0. Initially, we should
always give the stress on the maximal expression of the target gene
which is our ultimate objective. That is, as it is seen from equation
(4), initially l should be kept small. As we go from l=0.1 to
l=1.0, it implies that we are increasing the stress on the
constraint, and finally both the amount of yield (z) and the
constraint are treated equally. For each value of l, we minimize
the objective function of equation (4) where z is given by equation
(1) to obtain a proper set of values for ci’s for which y attains a
minimum value. We consider that set of ci-values corresponding to
l as the final solution, for which y becomes minimum. Indeed it
can be seen that l can be legitimately be called the regularizing
parameter.
Figure 1. Path diagram for apoptotic genetic network. Two optimal regulatory pathways obtained by the present method are shown by bold
black arrows, and one extreme regulatory pathway obtained by the extreme pathway analysis is shown by white arrows.
doi:10.1371/journal.pone.0012475.g001
Gene Regulatory Pathways
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reactions in the stoichiometric matrix and then the integrated
network can be analyzed by using extreme pathway analysis. The
main difference to this work is that modeling based on the
stoichiometric matrix requires a flux through the regulatory
network. This approach is valuable for identifying underlying
regulatory pathways in a regulatory network. Models such as
regulatory FBA attempt to explicitly model regulation by switching
Figure 2. Path diagram for the subnetwork indicating the main interactions between GAD and GABA-receptors during the development of
r a tc e r v i c a ls p i n a lc o r d .The optimal regulatory pathway is shown by bold black arrows and the extreme regulatory pathway is shown by white arrows.
doi:10.1371/journal.pone.0012475.g002
Figure 3. Path diagram for the Th regulatory network that controls the differentiation of Th cells in human. The optimal regulatory
pathway is shown by bold black arrows and the extreme regulatory pathway is shown by white arrows.
doi:10.1371/journal.pone.0012475.g003
Gene Regulatory Pathways
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expression in various growth conditions.
A complete picture of cellular regulation must take into account
metabolic reactions and their interplay with the regulatory layer.
Regulated flux balance analysis (rFBA) is a modeling approach that
aims to integrate regulation and metabolism. A major problem in
using ordinary differential equations (ODEs) for describing biochem-
ical reactions is the scarcity of experimental data on rate constants.
rFBA addresses this problem by assuming that the network is in a
steady state and therefore that the total concentration of each
substance does not change under this assumption, a system of ODEs
is transformed into a system of linear equations, and its rates can be
obtained by solving a linear programming problem that optimizes a
certain objective function. Such optimization problems can be solved
efficiently. Further constraints are added to narrow the solution
space. For example, the rate constants are restricted according to the
catalytic capacities of transcription factors. The method has been
successfully used to model large regulatory networks covering the
near complete regulation of several species.
A major difficulty of modeling regulatory networks is the context-
specific nature of gene regulation. The total space of possible
transcriptional regulatory interactions for an organism is the number
of transcription factors multiplied by the number of genes multiplied by
the number of environmental contextsin which the cell might find itself.
Here we have explored a framework for modeling transcrip-
tional regulatory networks in which experimental design and
validation are central features. This framework is based on
computational analysis suggesting a high-throughput strategy for
mapping gene-regulatory pathways.
Apoptotic Genetic network
The genetic network in Fig. 1 represents a part of apoptosis
regulation [13]. Apoptosis is one of the main types of programmed
cell death, which involves a series of biochemical events leading to
specific cell morphology, characteristics and ultimately death of
cells. A family of proteins known as caspases is activated in the
early stages of apoptosis [29]. Induction of apoptosis via death
receptors typically results in the activation of an initiator caspase
such as CASP 8 or CASP 10. These caspases can then activate
other caspases in a cascade. This cascade eventually leads to the
activation of the effector caspases, such as CASP 3 and CASP 6.
These caspases are responsible for the cleavage of the key cellular
proteins, such as cytoskeletal proteins, that leads to the typical
morphological changes observed in cells undergoing apoptosis.
There are 23 genes, 33 internal flows and no external flows present
in Fig. 1.
The starting genes are FasLand TNFa, and the target gene is
DFF45 (Fig. 1). Here z is defined as z~c26v26zc27v27{c25v25.
Following the method described in Section Method, we have obtained
the 2 optimal regulatory pathways as p1 : v3?v4?v10?v20?v26,
p2 : v5?v6?v8?v10?v16?v14?v15?v18?v27 as shown by bold
b l a c ka r r o w s .T h e s ea r et h et w om a j o re x p e r i m e n t a l l yc o n f i r m e d
pathways (extrinsic and intrinsic apoptosis pathways) p1 and p2 [30]
through which apoptosis can be triggered in a cell. The extreme
regulatory pathway obtained by the extreme pathway analysis is
different from that obtained by the proposed method and is as follows
v5?v6?v8?v9?v24?v27 as shown by white arrows.
Table S1 shows a few pathways from the starting gene to the
target gene along with c-values and the average amount (z) of the
protein synthesized by the target gene DFF45. Since, we have
generated a set of flow vectors, we have considered average of
these vectors to compute the average amount of the protein
synthesized (z). For example, the pathways p1 and p2 correspond-
ing to serial number 4 and 5 in Table S1 yield the highest average
z, and hence these are the optimal regulatory pathways. It can be
inferred from Table S1 that the corresponding c-values for the
Figure 4. Path diagram for the Th regulatory network that controls the differentiation of Th cells in mouse with feedback. The
optimal regulatory pathway is shown by bold black arrows and the extreme regulatory pathway is shown by white arrows.
doi:10.1371/journal.pone.0012475.g004
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other pathways. Thus it can be inferred from the c-values and the
z-values that the present method is able to correctly identify the
optimal gene regulatory pathways.
We have varied the upper bound of the flow values to show the
variation of transcription factors (c-value) and the amount (z) of the
protein synthesized by the target gene. The results are provided in
Table S2 for some high and low upper bounds. It is clear from
Table S2 that z-value, as expected, decreases with the decrease in
upper bound. In all the cases, we have found the same optimal
path although absolute c-values differ. This shows the consistency
of the present method in determining optimal gene regulatory
paths.
Genetic network for the development of rat cervical
spinal cord
Fig. 2 is a genetic network connecting 65 mRNA species during
the development of rat cervical spinal cord. The figure represents
the interaction of GAD (glutamic acid decarboxylase) and GABA-
R( c-amino butyric acid receptors). In a rat, two forms of GAD
exist, GAD65 and GAD67, as shown in Fig. 2. GABA, synthesized
from glutamate by GAD, is a well-known fast-acting synaptic
transmitter in the mature CNS [23]. However, it is also thought to
play an important role in CNS differentiation during early CNS
development.
In Fig. 2, the starting gene is GAD65 and the target gene is
G67186. There are 17 genes and 31 interactions in the network.
The expression for z is given by z~c9v9zc13v13zc22v22zc27v27.
Here an optimal pathway has been found to be p1 : v3?v15?v22 as
shown by bold black arrows. The extreme regulatory pathway
obtained by the extreme pathway analysis is different from that
obtained by the present method and is as follows v3?v15?v20?v27
as shown by white arrows.
Th regulatory network of human
Fig. 3 represents the Th regulatory network that controls the
differentiation of T-helper (Th) cells. Here the starting gene is TCR
and the target gene is ST AT3. The immune system of our body
contains diverse cell populations such as antigen presenting cells,
natural killer cells, B and T lymphocytes. T lymphocytes are classified
as either T helper cells (Th) or T cytotoxic cells (Tc). T helper cells take
part in cell and antibody-mediated immune responses by secreting
various cytokines, and they are further sub-divided into precursor Th0
cells, and effector Th1 and Th2 cells, depending on the array of
cytokines that they secrete [31]. The network that controls the
differentiation from Th0 towards the Th1 or Th2 phenotypes is a
complex network [25]. Here we have used an updated version of the
Th network in human where there is no feedback loop. There are 33
reactions and 23 genes in the network. Here we have z~
c21v21{c33v33. An optimal pathway obtained by the present method
is v1?v4?v10?v11?v12?v22?v27?v16?v17?v19?v20?v21 as
shown by bold black arrows. The extreme regulatory pathway
obtained by the extreme pathway analysis is different from that
obtained by the present method and is as follows v1?
v4?v10?v11?v12?v30?v15?v16?v17?v19?v20?v21 as shown
by white arrows.
Regulatory networks with feedback: Th regulatory
network of mouse
The genes GATA3 and T-bet in the Th regulatory network of
mouse (Fig. 4) as considered by Mendoza in [25] include a self-
activation loop. In order to incorporate these feedback loops in our
methodology, we have considered two hypothetical nodes
GATA3-1 and T-bet-1 analogous to the nodes corresponding to
the genes GATA3 and T-bet. Thus the order of the node-edge
incidence matrix becomes (mz2)|(nz4), where m is the
number of genes and n is the number of regulatory interactions.
The optimal regulatory pathway obtained by our method after
incorporating these two hypothetical genes remains the same as in
the case of Fig. 3. This is due to the fact that c-values
corresponding to the edges connecting actual and hypothetical
nodes are found to be small compared to that of the other edges.
The extreme regulatory pathway also remains the same as before.
Biological relevance and validation
Here we provide relevance and validation of the results from
biological point of view. For this purpose, we have searched the
literature, and validation of the results is made based on the results
obtained by earlier investigations.
Apoptotic Genetic network
Apoptosis is a complex process that proceeds through at least
two main pathways (extrinsic and intrinsic), each of which can be
regulated at multiple levels. The extrinsic pathway consists of cell
surface receptors, their inhibitory counterparts and their associ-
ated cytoplasmic proteins. The intrinsic pathway centers on the
mitochondria, which contain key apoptogenic factors such as
cytochrome c, AIF, SMAC/DIABLO, Htra2/Omi and endoG.
In the case of apoptotic genetic network, the biological
significance of the two major experimentally confirmed pathways
(extrinsic and intrinsic apoptosis pathways) p1 and p2 [30] as
obtained by the present method in Fig. 1 is described here. The
pathway p1 has FasL as the initial gene and DFF45 as the target
gene. There are three paths emerging from the intermediate gene
FADD. The path involving the flows v9 to v28 is not followed as it
does not lead to the target gene DFF45. There are three paths
emerging from the intermediate gene CASP10. The path involving
v22 is not followed as it does not yield the target gene. Though the
other two paths involving v23 and v24 yields the target gene but they
are not followed. The other path from FADD through v11 is not
followed as it leads to the formation of the gene CASP2 which is not
the desired target gene. The occurrenceof the gene FADD hasbeen
observed in [32–34]. The optimal regulatory path leads from
FADD to CASP8 whose occurrence has been demonstrated in [35].
There are four paths emerging from the intermediate gene CASP8.
The path through v19 is not followed as it does not yield the target
gene. We reach the target gene through the flow v20. The existance
of the path through v20 and v26 to yield the target gene is established
in [36,37] in contrary to the other two paths through v16 and v21.
Moreover, the path through v21 yielding CASP3 as the intermediate
gene cannot be followed and has been explained in [38]. The
extrinsic apoptotic pathway p1 as derived by the regularization
method has been observed in [39–42].
The pathway p2 has TNFa as the initial gene and DFF45 as the
target gene. After reaching the intermediate gene TRADD the
path divides into two branches. The occurrence of the gene
TRADD in the apoptotic path has been observed in [43]. The
path through v7 is not followed as it ultimately terminates to the
gene CASP2 which is not the desired target gene DFF45. The
path through v8 is followed. From the intermediate gene FADD,
three paths emerge of which the path through v10 is followed till
we reach the intermediate gene CASP8. It has already been
explained in the previous paragraph that the other two paths
through v9 and v11 are not followed. There are four paths
emerging from CASP8. The path through v16 yielding Cytc, Apaf-
1 and CASP9 is followed. From CASP9 the path through v17 is not
followed as it terminates to the gene CASP2, which is not the
Gene Regulatory Pathways
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intermediate gene is followed. From CASP3, the path through v33
is not followed as it terminates to the gene CASP6, which is not the
target gene. So the path through v27 yielding DFF45 as the target
gene is followed. Of the remaining three paths from CASP8, the
path through v19 is not followed as it terminates to the gene
CASP2 that is not the desired target. The path through v21
yielding CASP3 as the intermediate gene cannot occur biologically
and has been explained in the previous paragraph. The path
through v20 yielding CASP7 as the intermediate gene is a subpath
of the extrinsic pathway. The intrinsic apoptotic pathway p2 as
derived by the present method has been observed in [40,41].
Starting from the gene TNFa, both the extreme pathway
analysis and the present method follow the same path till they
arrive at the intermediate gene FADD. The existance of the
optimal pathway through the genes TNFa, TNFR1, TRADD and
FADD has been observed in [44–46]. From FADD, the path
obtained by our present method coincides with the intrinsic and
the extrinsic pathway and not the path obtained by extreme
pathway analysis. The intrinsic path that leads from FADD to the
target gene DFF45 through the intermediate path as obtained by
the present method can be found in [47–49].
The acquired biological knowledge of the apoptosis regulatory
network can be translated into mathematical models, in particular
focusing on the regulatory events. Two distinct modeling
approaches i) Modeling by deterministic ODEs and ii) stochastic
CA-based (cellular automation) models that determines regulatory
pathways from experiments exist in the literature. The pathways
obtained by our method coincide with those pathways determined
by both ODE and CA-based models for the apoptosis regulatory
network [50].
Genetic network for the development of rat cervical
spinal cord
In Fig. 2, there are 11 paths emerging from the starting gene
GAD65 of the genetic network for the development of rat cervical
spinal cord. The paths through v1, v2 and v10 are not followed as
they terminate to the intermediate genes GAD67, GRg2 and
GRb3 respectively, which are not the desired targets. The paths
through v8 and v9 do not lead to the optimal path. The path
following v11 terminates to the intermediate gene GRa4. From
GRa4, we can reach the target gene G67186 through v27 but this
path is not followed. The other path through v28 from GRa4 is not
followed as it terminates to another intermediate gene GRg3 that
is not the required target. Another path through v12 reaches the
intermediate gene preGAD67. From preGAD67, the paths
leading through v19, v21, v23, v24 and v26 are not followed as they
terminate to some intermediary genes and are not the target gene.
The path through v20 from preGAD67 ultimately leads to the
target gene by the flow v27 but is not followed. The path through
v22 does not lead to the optimal path. The paths through v15, v5
and v4 do not reach the desired target and hence are not the
optimal paths. The path leading through v3 is followed till we
reach the intermediate gene GRa3. Of the 3 paths emerging from
GRa3, the paths through v14 ends up at an intermediate gene
GRb1 and the other path through v13 is not the optimal path. So
the only remaining path from GRa3 through v15 is followed which
ultimately leads to the target gene G67186 by the flow v22, and this
sequence of steps forms the desired optimal regulatory pathway.
The importance of the starting gene GAD65 and the intermediate
gene GRa3 in the optimal regulatory pathway has been observed
in [51,52]. The pathway obtained by the present method follows
[53], in contrary to the path obtained by the extreme pathway
analysis.
Th regulatory network
The Th regulatory network in Fig. 3 has TCR as the starting
gene and STAT3 as the target gene. The biological significance of
the path that we have derived by our algorithm is described here.
The path follows from TCR through NFAT, IFN-c, IFN-cR,
JAK1 till we reach the intermediate gene STAT1. The path gets
divided into three branches at the intermediate gene STAT1. The
path through v14 is not followed as the path from another
intermediate gene SOCS1 through v28 follows a self loop. So the
path through v22 is followed through SOCS1, IL-4R, STAT6,
which is the same as obtained from our method till we arrive at
another intermediate gene GATA3. There are three paths
emerging from GATA3. The paths through v18 and v32 are not
followed as they end up in a loop structure. So the path through
v19 is followed to reach the target gene which is the same as
obtained from our present method and is found in [54,55].
Selective activation of T helper (Th) cell subsets plays an
important role in the pathogenesis of human allergy and
inflammatory diseases. Dissecting pathways and regulatory
networks leading to the development of Th1 or Th2 cells will be
crucial to understand the pathogenesis of allergy and inflammatory
diseases. Improved understanding may lead to better strategies for
developing diagnostics and effective therapies for these diseases.
The recent results have led to novel hypotheses on the
transcription factors involved in human Th cell differentiation.
Effort has been given at elucidating the function of the novel genes
and pathways identified from literature with primary human
CD4+ T cells. Detailed analysis of upstream T cell Receptor
(TCR)/key cytokine receptor induced regualtory pathways
includes repeated rounds of mathematical modelling and exper-
imental verification. The signalling and transcriptional protein
complexes are analyzed with mass spectrometry and cell imaging
techniques to build a model of T cell activation and differentiation.
Prostate genetic network, Multiple-myeloma (MM) tissue
genetic network and SOS genetic network
The target gene CAV1 on the optimal regulatory path in Fig.
S3 (in the Prostate genetic network in Text S1) was involved in
breast cancer [56] and ovarian carcinoma [57]. It was reported
that the gene DF on the optimal regulatory path in Fig. S5 (in the
(MM) tissue genetic network in Text S1) was a novel serine
protease [58] and was involved in myeloid cell differentiation [59].
The gene AX1 on the optimal regulatory path was a tyrosine
kinase receptor and was recently found down regulated in mature
bone marrow-derived dendritic cells [60].
The SOS pathway in Fig. S6 (in the SOS genetic network in
Text S1), which regulates cell survival and repair after DNA
damage, involves the lexA and recA genes [1]. There are 3 paths
emerging from the starting gene lexA in Fig. S6. The paths leading
through v1 and v3 are not followed as they terminate to the
intermediate genes umuDC and dinI which are not the required
targets. The only remaining path through v4 is followed till the
intermediate gene ssb is reached. There is a single path from ssb
leading to the target gene rpoD through v12, which is the desired
optimal regulatory pathway. The importance of the starting gene
lexA, the intermediate gene ssb and the target gene rpoD has been
observed in [28,61,62].
Discussions on the present method: Impact on genetic
engineering
The computational prediction of all biologically relevant or
novel alternative routes in regulatory networks has numerous
applications in systems biology. The present method can be
Gene Regulatory Pathways
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expressing/inhibiting optimal pathways, under the framework of
genetic engineering. Here we describe briefly such a problem on
the production of fermentative hydrogen and show how the
present method may be applicable to this problem.
Microorganisms produce hydrogen via two main pathways:
photosynthesis and fermentation. Here we consider microbial
production of hydrogen by fermentation (more advantageous than
the photosynthetic hydrogen production) and provide an overview
to enhance fermentative hydrogen production through genetic
engineering. We have chosen to genetically engineer E. coli [63] for
hydrogen production as this is the best-characterized bacterium
(i.e. has well-established metabolic pathways) and it is one of the
easiest strains to manipulate genetically. The fermentative route of
hydrogen production in E. coli (Fig. 5) starts with the conversion of
glucose to pyruvate, which is then converted to acetyl-CoA and
formate, which is catalysed by pyruvate formate lyase (PFL).
Biological hydrogen production from formate is catalyzed by the
formate hydrogen lyase (FHL) complex. The FHL complex of E. coli
has been the most extensively characterized at both the physiolog-
ical and genetic levels.
Hydrogen is produced from glucose by fermentation with the
simultaneous release of carbondioxide which is not hydrogen
hogging, instead of water which is released during photosynthesis.
As we proceed along the hydrogen producing pathway the
intermediate steps leading to production of succinate, lactate,
acetate and ethanol involve hydrogen. As our ultimate goal is to
maximize the target product hydrogen we have to disrupt/block
the hydrogen hogging pathways and enhance the pathways that
produce hydrogen. It has been observed from our methodology
that the values of the flux vectors along the path that yields
hydrogen from glucose via pyruvate gradually increases in
contrary to the values of the fluxes that gradually decreases along
the intermediate hydrogen hogging pathways (Table 1). This
ultimately leads to maximal production of hydrogen from glucose
via pyruvate simultaneously blocking other intermediate steps that
produce succinate, lactate, ethanol and acetate. Thus we can
conclude that our proposed methodology has been successful in
deriving the optimal path from glucose to generate maximum
amount of hydrogen.
The fermentative hydrogen metabolism in E. coli is determined
by 50 genes distributed across 20 distinct genetic loci [64]. The
modification of transcriptional regulators and enzymes are needed
for the coordinated engineering of genes and operons that perform
distinct biochemical functions related to the production of
hydrogen. Here Fan et. al. have described a method for achieving
increased molar yield of hydrogen by modifying certain genes
involved in the pathway that produces hydrogen from glucose
under anaerobic conditions and globally regulate the fermentative
hydrogen production in E. coli.
There are two possible ways through which improved hydrogen
yields from glucose can be achieved. The first involves directing
glucose metabolism toward pyruvate formate lyase (PFL) by
disrupting the succinate-producing and lactate-producing path-
ways. The second encompasses enhanced downstream pathways
of PFL through overexpression of the formate hydrogen lyase
(FHL) complex. Since the genes fhlA and hycA control the
transcription of the FHL complex, it is theoretically possible to
control the specific FHL activity and the specific hydrogen
production rate by manipulating these genes or their genetic
controls. The fermentative biohydrogen production from formate
can be increased by overexpressing the FHL activator encoded by
the fhlA and by inactivating the FHL repressor encoded by the
hycA in E. coli K-12 strain W3110. The present method becomes
useful if we can increase the transcription factor and hence
increase the expression level of the gene fhlA and decrease the
transcription factor for the gene hycA for the corresponding
optimal regulatory path. Moreover, it has been experimentally
observed in [65,66] that the hydrogen production rate was 2.8-fold
higher with both fhlA overexpressed and hycA inactivated in E. coli
K-12 strain W3110.
Enhanced hydrogen yield from glucose can also be obtained by
blocking the competing lactate (via deleting the gene ldhA) and
succinate (via deleting the gene frdBC) production pathways. Our
method becomes effective for this case if we can decrease ldhA and
frdBC, and/or their transcription activators for ldhA and frdBC.
Thus it can be concluded that blocking some pathways (decreasing
the expression levels of the genes and/or their transcription
activators in the path) through mutagenesis results in enhanced
hydrogen production from glucose.
If the transcription factors affect the target gene(s) positively,
then the expression level(s) of the target gene(s) increase and vice
versa. Our method becomes useful if we can increase the
Figure 5. Fermentative hydrogen production pathway from
glucose by E. coli. The bold white arrows are the pathways inactivated
by disrupting ldhA and frdBC, and the bold black arrows are the
pathways enhanced by disrupting hycA and over expressing fhlA.
doi:10.1371/journal.pone.0012475.g005
Table 1. Values of flux vectors for the system in Fig. 5.
Serial
Number
Intermediate steps
in the pathway
Flux
vector v
1 Glucose?Phosphoenolpyruvate 19.57
2 Phosphoenolpyruvate?Pyruvate 26.73
3 Phosphoenolpyruvate?Succinate 8.75
4 Pyruvate?Lactate 7.34
5 Pyruvate?Acetyl-CoA 6.92
6 Acetyl-CoA?Ethanol 5.22
7 Acetyl-CoA?Acetate 5.06
8 Pyruvate?Formate 30.45
9 Formate?Hydrogen 35.29
doi:10.1371/journal.pone.0012475.t001
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gene(s) to make that pathway active. If we want to switch off any
pathway we have to reduce the gene expression level and hence
decrease the transcription factor for that corresponding path.
However, the present method can be useful for this example to
determine an optimal regulatory pathway through which the
amount of hydrogen is maximum. We can apply the method to
this problem for determining the optimal gene regulatory pathway
and finally express this optimal path. Discovering novel optimal
gene regulatory pathways through genetic engineering may also
help to make biological hydrogen production more favorable,
practical and commercially competitive.
Discussion
Here we have developed a network based algorithm for
exploring gene regulatory networks in which the underlying
optimal regulatory pathways from a starting gene to a target gene
can be determined in terms of concentration of various
transcription factors regulating the genes in the network. In other
words, the method determines an optimal set of transcription
factors that need to be expressed to get an optimal gene regulatory
pathway from starting gene(s) to target gene(s).
The effectiveness of the regularization method has been
demonstrated on ten gene regulatory networks to infer optimal
regulatory pathways which has practical applications in the field of
genetic engineering. The significance of the optimal pathways has
been biologically validated through extensive literature survey.
Finally we have shown with an example how the method can be
effectively used in the field of genetic engineering. As regulatory
networks are reconstructed with a matrix formalism as presented
herein, these analysis tools can be used to characterize funda-
mental features of such systems.
Information about gene regulatory pathways can be used to
infer topological features and regulatory interactions of the
network. However, it is known that regulatory pathways do not
persist over all time. An important recent finding in which the
above is seen to be true is following examination of regulatory
networks during the yeast cell cycle, wherein topologies change
depending on underlying (endogeneous or exogeneous) cell
condition.
In order to describe the knowledge on regulatory pathways for
simulation, a considerable amount of attention have been paid to
Petri net for details. Petri net is a network consisting of place,
transition, arc, and token. The conventional Petri net can be used
to model only the discrete features in biological pathways, e.g.
logical regulatory relationships between genes. But biological
pathway modeling requires some continuous features with enzyme
reactions represented with differential equations.
Cancer is a heterogeneous disease often requiring a complexity
of alterations to drive a normal cell to a malignancy and ultimately
to a metastatic state. In cancer research, microarray technology
measures the gene expressions of cancer and normal tissues and
identifies genes that are differentially expressed between cancerous
and normal cells. The set of individual differentially expressed
genes can only tell us which genes are altered by biological
differences between different cell types and/or states. It cannot
explain the reasons for the significant alterations in gene
expression levels and the effects of such changes on other gene
activities. In a biological system genes interact with each other
forming various regulatory pathways in order to carry out a
multitude of biological processes. To better understand the roles of
these differentially expressed genes and their interactions in a
complex biological system, a comprehensive pathway analysis is
needed. Since the identification of regulatory pathways is
significantly influenced by those differentially expressed genes
from different datasets or different statistical methods, an
integration of multiple cancer microarray datasets and identifica-
tion of the most common pathways from these data would reveal
key relationships between crucial genes in carcinogenesis.
Methods
A gene regulatory network can be represented as a directed
graph where the nodes represent genes and the directed edge
represents the regulatory relationship between two connected
genes. Let  gi be the expression level of gene i associated with node
i in the graph. There is a flow, associated with each directed edge
(i, j) from node i to node j, which indicates the flow of mRNA and
thereby protein obtained from gene i transported through the edge
(i, j). This protein now binds to gene j and regulates its expression
level. It is to be mentioned here that we are using the flow of
mRNA and proteins interchangeably. That is, we are considering
only those fractions of mRNAs that are not degraded by any other
factors, and form proteins through translation.
Here we present a method for identifying an optimal gene
regulatory pathway from a starting gene to a target gene through
which the expression level of the target gene becomes maximum.
The genes on such an optimal pathway need to be expressed along
with other transcription factors regulating them. Transcription
factors bind to specific parts of DNA in the promoter region of a
gene and, thus, affect the transcription of the gene. They can
activate, enhance, or inhibit the transcription. Changes of
abundances of transcription factors cause changes in the amount
of transcripts of their target genes. This process is highly complex
and interactions among transcription factors result in a more
interwoven regulatory network.
The interactions among the genes describing their transcrip-
tional regulation are considered as a matrix, called a node edge
incidence matrix, B. The order of the matrix is m|n with m as the
number of genes and n as the total number of regulatory
interactions within a gene regulatory network. That is, the total
number of edges is n. An element eik of matrix B is 21( +1) if k-th
edge (interaction) exits (enters) the node corresponding to gene  gi.
Otherwise, eik =0. A system boundary is drawn around a gene
regulatory network which consists of both internal and exchange
flows. The internal flows are constrained to be positive and the
exchange flows can be either positive if the flow enters the
network, negative if the flow exits the network, or bidirectional.
There are n flows and m genes in the network. Let nI be the
number of internal flows and nE be that of exchange flows, and
then n~nIznE. The k-th internal flow is denoted by vk and the
l-th exchange flow is denoted by bl. So there are v1, ..., vnI
internal flows and vnIz1, ..., vn exchange flows where vnIzl~bl.
The target gene  g(t) can be reached through various paths from
the starting gene  g(i) (Fig. 6). There are s biochemical reactions/
conversions R1, R2, ...Rs in the network involving the target
gene  g(t).
We take the algebraic sum of the weighted flows of reactions
R1, R2, ...Rs to reach the target gene  g(t), and it is given by
z~
X s
k~1
ckvk ð1Þ
which needs to be maximized for yielding maximum expression
level of the target gene. The term ck denotes the weighting factor,
representing concentration of other transcription factors (not
shown in the diagram) to get the corresponding flow vk. The
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vectors; (ii) Formulation of a new constraint; and (iii) Estimation of
weighting coefficients ci.
There exists a well established methodology, called flux balance
analysis, in the context of metabolic pathway analysis. In such
analysis, a stoichiometric matrix is formed with the number of
rows as the number of metabolites and the number of columns as
the number of reactions (fluxes). The fluxes represent the rate of
mass flow from one metabolite to the other through a reaction. We
have extended this methodology to the analysis of gene regulatory
networks. Here we consider node-edge incidence matrix B, similar
to stoichiometric matrix in case of metabolic pathways. The flux
vectors are replaced by flow vectors where a component vij
represents the flow of mRNA and thereby the protein produced
from gene i to gene j. This protein becomes a transcription factor
of gene j for its regulation. Thus, flow of mRNA and thereby
proteins obtained from a gene and binding these proteins into
another gene is considered as a chemical reaction as in the case of
metabolic pathways.
Generation of gene flow vectors
In this step, we generate some possible flow vectors for a gene
regulatory network. The flow vectors satisfy approximately the
quasi-steady state condition. That is, we generate those v which
satisfies
Bv&0 ð2Þ
where B is the m|n node-edge incidence matrix that describes the
regulatory interactions among genes. B is computed from a given
gene regulatory network. As n w m, equation (2) is under
determined. So we proceed in the following way:
a): Generate basis vectors vb that span the null space of the
node-edge incidence matrix B. Let the number of such basis
vectors be p. (This is done by standard functions available in
MATLAB).
b): Generate p random numbers aj, j~1, 2, ..., p. Then
generate a vector v as a linear combination of the basis vectors
using ap i.e., v~
Pp
j~1 ajvbj. We consider those v for which certain
boundary conditions are satisfied for each of its components [12].
That is, vk (kth component of v) is an internal flow, vk§0. For vk
to be an exchange flow, vk§0( ƒ0), if the flow enters (exits) the
network. If the exchange flow is bidirectional, {?ƒvkƒ?.
Incorporating feedback
A gene regulatory network often contains one or more
feedback loop(s). In order to incorporate the effect of feedback
possessed by a gene  g, we consider a hypothetical node  g1,i n
addition to the node corresponding to gene  g (Fig. 7), as it is not
possible to put an entry corresponding to a feedback in the node-
edge incidence matrix B. Then flows are made from  g to  g1
and  g1 to  g. Thus the number of rows of B is increased by 1,
and the number of columns of B and the number of components
of the flow vector are increased by 2 due to a single feedback.
Now both B and the flow vectors v are generated by the above
steps.
Formulation of a new constraint
All the transcription factors that are not shown in a system may
not be expressed at the required level so that the corresponding
target genes may not be expressed/inhibited fully. This imposes
further restrictions on the system and leads to variation in the
concentration of other transcription factors. Thus we define a new
constraint as
B(Cv)~0 ð3Þ
where C is an n|n diagonal matrix, whose diagonal elements are
the components of the vector c. That is, if C~½cij n|n, then
cij~dijci, where dij is the Kronecker delta. Thus the problem of
determining an optimal regulatory pathway from a starting gene to
a target gene boils down to an optimization problem, where z has
to be maximized with respect to c, such that the aforesaid
inequality constraints and the new constraint are satisfied.
Estimation of weighting coefficients ci
Combining equations (1) and (3), we can reformulate the
objective function as
y~1=zzL
T(B(Cv)) ð4Þ
that needs to be minimized with respect to the weighting factors ci
for all i. The term L~½l1, l2, ..., lm 
T is called Lagrange’s
multiplier or regularizing parameter. For the sake of simplicity, we
have considered here l1~...~lm~l (say). Initially, a set of
random values in ½0, 1  corresponding to ci’s are generated. Then
ci’s are modified iteratively using gradient descent technique,
Figure 7. Incorporation of feedback loop. The feedback loop
around the node corresponding to gene  g is replaced by considering a
hypothetical node  g1, and edges ( g,  g1) and ( g1,  g).
doi:10.1371/journal.pone.0012475.g007
Figure 6. A hypothetical reaction network. The three dots
indicates the continuation of the biochemical reactions from R1 to Rs
involving s different paths to reach the target gene. The reactions R1,
R2 and Rs, involving the target gene, are shown in the diagram.
doi:10.1371/journal.pone.0012475.g006
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as
Dci~{g
Ly
Lci
ð5Þ
The term g is a small positive quantity indicating the rate of
modification. Thus the modified value of ci is ci(tz1)~
ci(t)zDci, Vi, t~0, 1, 2, ... ci(tz1) is the value of ci at
iteration (tz1), which is computed based on the ci-value at the
iteration t.
Regularization parameter l is chosen empirically from 0.1 to
1.0 in steps of 0.1. Using the above mentioned method, for each
value of l, we finally get ci-values for which y attains a minimum
value. We choose a specific l for which the y-value is the
minimum over all the minima attained for different values of l.
The concentration vector ci attains values between 0 to 1 as
mentioned previously corresponding to some values of vk and is
negligible for other values of vk. We take into account the values of
ci’s that are close to 1, corresponding to the minimum value of y.
This enables us to identify the optimal regulatory pathway yielding
the maximal expression of the target gene g(t) starting from the
initial gene g(i).
Supporting Information
Text S1 Supplementary information.
Found at: doi:10.1371/journal.pone.0012475.s001 (0.08 MB
PDF)
Table S1 Some possible pathways with their c-values and z-
values for the system in Fig. 1.
Found at: doi:10.1371/journal.pone.0012475.s002 (0.01 MB
PDF)
Table S2 Variation of c-values and z-values with the upper
bound on regulatory flows for the optimal path p1:
v3Rv4Rv10Rv20Rv26 of the system in Fig. 1.
Found at: doi:10.1371/journal.pone.0012475.s003 (0.01 MB
PDF)
Figure S1 Path diagram for a genetic network reconstructed
from yeast cell cycle data. The 3 optimal regulatory pathways are
shown by bold black arrows.
Found at: doi:10.1371/journal.pone.0012475.s004 (0.24 MB TIF)
Figure S2 Path diagram of three complex regulatory circuits of
the extended transcriptional regulatory network of E. coli. The
optimal regulatory pathways are shown by bold black arrows and
the extreme regulatory pathway is shown by white arrows for part
C.
Found at: doi:10.1371/journal.pone.0012475.s005 (0.52 MB TIF)
Figure S3 Path diagram for prostate genetic network. The
optimal regulatory pathway is shown by bold black arrows.
Found at: doi:10.1371/journal.pone.0012475.s006 (0.27 MB TIF)
Figure S4 Path diagram for yeast cell cycle genetic network. The
optimal regulatory pathway is shown by bold black arrows.
Found at: doi:10.1371/journal.pone.0012475.s007 (0.23 MB TIF)
Figure S5 Path diagram for differentially regulated genetic
network for the MM data set. The optimal regulatory pathway is
shown by bold black arrows.
Found at: doi:10.1371/journal.pone.0012475.s008 (0.24 MB TIF)
Figure S6 Path diagram of the interactions of the SOS network.
The optimal regulatory pathway is shown by bold black arrows.
Found at: doi:10.1371/journal.pone.0012475.s009 (0.19 MB TIF)
Acknowledgments
We would like to thank the Anonymous Referees for their fruitful
suggestions for improving the content of the presentation.
Author Contributions
Conceived and designed the experiments: MD RKD. Performed the
experiments: MD. Analyzed the data: MD RKD. Wrote the paper: MD
SM RKD.
References
1. Gardner TS, di Bernardo D, Lorenz D, Collins JJ (2003) Inferring Genetic
Networks and Identifying Compound Mode of Action via Expression Profiling.
Science 301: 102–105.
2. Datta S (2001) Exploring Relationships in Gene Expressions: A Partial Least
Squares Approach. Gene Expr 9: 249–255.
3. Schilling CH, Edwards JS, Letscher D, Palsson BO (2001) Combining pathway
analysis with flux balance analysis for the comprehensive study of metabolic
systems. Biotechnology and Bioengineering 71: 286–306.
4. Urbanczik R, Wagner C (2005) An improved algorithm for stoichiometric
network analysis: theory and applications. Bioinformatics 21: 1203–1210.
5. Schwartz J-M, Kanehisa M (2006) Quantitative elementary mode analysis of
metabolic pathways: the example of yeast glycolysis. BMC Bioinformatics 7: 186.
6. Lee JM, Gianchandani EP, Papin JA (2006) Flux balance analysis in the era of
metabolomics. Briefings in Bioinformatics 7: 140–150.
7. Wagner C, Urbanczik R (2005) The geometry of the flux cone of a metabolic
network. Biophysical Journal 89: 3837–3845.
8. Covert MW, Palsson BO (2003) Constraints-based models: Regulation of gene
expression reduces the steady-state solution space. Journal of Theoretical Biology
221: 309–325.
9. Palsson BO, Price ND, Papin JA (2003) Development of network-based pathway
definitions: the need to analyze real metabolic networks. Trends in Biotechnol-
ogy 21: 195–198.
10. Gianchandani EP, Papin JA, Price ND, Joyce AR, Palsson BO (2006) Matrix
Formalism to Describe Functional States of Transcriptional Regulatory Systems.
PLoS Computational Biology 2(8): e101. doi:10.1371/journal.pcbi.0020101.
11. Troein C, Ahren D, Krogh M, Peterson C (2007) Is Transcriptional Regulation
of Metabolic Pathways an Optimal Strategy for Fitness? PLoS ONE 2(9): e855.
doi:10.1371/journal.pone.0000855.
12. Schilling CH, Letscher D, Palsson BO (2000) Theory for the Systemic Definition
of Metabolic Pathways and their use in Interpreting Metabolic Function from a
Pathway-Oriented Perspective. J Theor Biol 203(3): 229–248.
13. Xiong M, Zhao J, Xiong H (2004) Network-based regulatory pathways analysis.
Bioinformatics 20(13): 2056–2066.
14. Feldman I, Rzhetsky A, Vitkup D (2008) Network properties of genes harboring
inherited disease mutations. PNAS 105(11): 4323–4328.
15. Altman RB, Raychaudhuri S (2001) Whole-genome expression analysis:
challenges beyond clustering. Current Opinion in Structural Biology 11(3):
340–347.
16. Loscalzo J, Kohane I, Barabasi AL (2007) Human disease classification in the
postgenomic era: A complex systems approach to human pathobiology.
Molecular Systems Biology 3: 124. doi:10.1038/msb4100163.
17. Dodge-Kafka KL, Soughayer J, Pare GC, Carlisle Michel JJ, Langeberg LK,
et al. (2005) The protein kinase A anchoring protein mAKAP coordinates two
integrated cAMP effector pathways. Nature 437: 574–578.
18. Hauser MA, Li YJ, Takeuchi S, Walters R, Noureddine M, et al. (2003)
Genomic convergence: identifying candidate genes for Parkinson’s disease by
combining serial analysis of gene expression and genetic linkage. Human
Molecular Genetics 12(6): 671–677.
19. Schadt EE, Lamb J, Yang X, Zhu J, Edwards S, et al. (2005) An integrative
genomics approach to infer causal associations between gene expression and
disease. Nat Genet 37(7): 710–717.
20. Lee DS, Park J, Kay KA, Christakis NA, Oltvai ZN, et al. (2008) The
implications of human metabolic network topology for disease comorbidity.
PNAS 105(29): 9880–9885.
21. Braun P, Rietman E, Vidal M (2008) Networking metabolites and diseases.
PNAS 105(29): 9849–9850.
22. Goh K, Cusick ME, Valle D, Childs B, Vidal M, et al. (2007) The human
disease network. PNAS 104(21): 8685–8690.
23. D’haeseleer P, Wen X, Fuhrman S, Somogyi R (1999) Linear Modeling of
mRNA Expression Levels During CNS Development and Injury. http://helix-
web.stanford.edu/psb99/Dhaeseleer.pdf, DBLP, http://dblp.uni-trier.de Pacific
Symposium on Biocomputing 4: 41–52.
Gene Regulatory Pathways
PLoS ONE | www.plosone.org 10 September 2010 | Volume 5 | Issue 9 | e1247524. Mendoza L, Xenarios I (2006) A method for the generation of standardized
qualitative dynamical systems of regulatory networks. Theoretical Biology and
Medical Modelling 3: 13. doi:10.1186/1742-4682-3-13.
25. Mendoza L (2006) A network model for the control of the differentiation process
in Th cells. Biosystems 84: 101–114.
26. Ma H-W, Kumar B, Ditges U, Gunzer F, Buer J, et al. (2004) An extended
transcriptional regulatory network of Escherichia coli and analysis of its
hierarchical structure and network motifs. Nucleic Acids Research 32(22):
6643–6649.
27. Xiong MM, Li J, Fang X (2004) Identification of genetic networks. Genetics 166:
1037–1052.
28. Yamanaka T, Toyoshiba H, Sone H, Parham FM, Portier CJ (2004) The TAO-
Gen Algorithm for Identifying Gene Interaction Networks with Applications to
SOS Repair in E.coli. Environmental Health Perspectives 112(16): 1614–1621.
29. Ghobrial IM, Witzig TE, Adjei AA (2005) Targeting Apoptosis Pathways in
Cancer Therapy. CA Cancer J Clin 55: 178–194.
30. Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF (2003) Apoptosis and lung
cancer: A review. Journal of Cellular Biochemistry 88: 885–898.
31. Murphy KM, Reiner SL (2002) The lineage decisions on helper T cells. Nature
Reviews Immunology 2: 933–944.
32. Chao W, Shen Y, Li L, Rosenzweig A (2002) Importance of FADD Signaling in
serum Deprivation- and Hypoxia-induced Cardiomyocyte Apoptosis. The
Journal of Biological Chemistry 277(35): 31639–31645.
33. Cicin-Sain L, Ruzsics Z, Podlech J, Bubic I, Menard C, et al. (2008) Dominant-
Negative FADD Rescues the In Vivo Fitness of a Cytomegalovirus Lacking an
Antiapoptotic Viral Gene. Journal of Virology 82(5): 2056–2064.
34. Takashina T, Nakayama M (2007) Modifications enhance the apoptosis-
inducing activity of FADD. Molecular Cancer Therapeutics 6(6): 1793–1803.
35. Martinez R, Setien F, Voelter C, Casado S, Quesada MP, et al. (2007) CpG
island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a
common hallmark of relapsed glioblastoma multiforme. Carcinogenesis 28(6):
1264–1268.
36. Chang HY, Yang X (2000) Proteases for Cell Suicide: Functions and Regulation
of Caspases. Microbiology And Molecular Biology Reviews 64(4): 821–846.
37. Cohen GM (1997) Caspases: the executioners of apoptosis. Biochem J 326: 1–16.
38. Saito K, Meyer K, Warner R, Basu A, Ray RB, et al. (2006) Hepatitis C Virus
Core Protein Inhibits Tumor Necrosis Factor Alpha-Mediated Apoptosis by a
Protective Effect Involving Cellular FLICE Inhibitory Protein. Journal of
Virology 80(9): 4372–4379.
39. Eimon PM, Kratz E, Varfolomeev E, Hymowitz SG, Stern H, et al. (2006)
Delineation of the cell-extrinsic apoptosis pathway in the zebrafish. Cell Death
and Differentiation 13: 1619–1630.
40. MacFarlane M, Williams AC (2004) Apoptosis and disease: a life or death
decision. EMBO Reports 5: 674–678.
41. Putcha GV, Harris CA, Moulder KL, Easton RM, Thompson CB, et al. (2002)
Intrinsic and extrinsic pathway signaling during neuronal apoptosis: lessons from
the analysis of mutant mice. The Journal of Cell Biology 157(3): 441–453.
42. Mongiat M, Ligresti G, Marastoni S, Lorenzon E, Doliana R, et al. (2007)
Regulation of the Extrinsic Apoptotic Pathway by the Extracellular Matrix
Glycoprotein EMILIN2. Molecular and Cellular Biology 27(20): 7176–7187.
43. Rokudai S, Fujita N, Kitahara O, Nakamura Y, Tsuruo T (2002) Involvement of
FKHR-Dependent TRADD Expression in Chemotherapeutic Drug-Induced
Apoptosis. Molecular and Cellular Biology 22(24): 8695–8708.
44. Morgan M, Thorburn J, Pandolfi PP, Thorburn A (2002) Nuclear and
cytoplasmic shuttling of TRADD induces apoptosis via different mechanisms.
The Journal of Cell Biology 157(6): 975–984.
45. Kieser A (2008) Pursuing different TRADDes: TRADD signaling induced by
TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1. Biological
Chemistry 389: 1261–1271.
46. Ishizawa Y, Tamura K, Yamaguchi T, Matsumoto K, Komiyama M, et al.
(2006) Xenopus death-domain-containing proteins FADD and R1P1 synergis-
tically activate JNK and Nf-kappaB. Biology of the Cell 98: 465–478.
47. Siwkowski AM, Madge LA, Koo S, McMillan EL, Monia BP, et al. (2004)
Effects of Antisense Oligonucleotide-Mediated Depletion of Tumor Necrosis
Factor (TNF) Receptor 1-Associated Death Domain Protein on TNF-Induced
Gene Expression. Molecular Pharmacology 66(3): 572–579.
48. Bulfone-Paus S, Bulanova E, Pohl T, Budagian V, Durkop H, et al. (1999) Death
deflected: Il-15 inhibits TNF-a-mediated apoptosis in fibroblasts by TRAF2
recruitment to the IL-15Ra chain. The FASEB Journal 13: 1575–1585.
49. Manna SK, Mukhopadhyay A, Aggarwal BB (2000) IFN-a suppresses activation
of nuclear transcription factors NF-kappa B and activator protein 1 and
potentiates TNF-induced apoptosis. The Journal of Immunology 165:
4927–4934.
50. Chen C, Cui J, Lu H, Wang R, Zhang S, et al. (2007) Modeling of the Role of a
Bax-Activation Switch in the Mitochondrial Apoptosis Decision. Biophysical
Journal 92: 4304–4315.
51. Stork O, Ji F-Y, Kaneko K, Stork S, Yoshinobu Y, et al. (2000) Postnatal
development of a GABA deficit and disturbance of neural functions in mice
lacking GAD65. Brain Research 865: 45–58.
52. Craver MPJ, Knoll LJ (2007) Increased efficiency of homologous recombination
in Toxoplasma gondii dense granule protein 3 demonstrates that GRA3 is not
necessary in cell culture but does contribute to virulence. Molecular and
Biochemical Parasitology 153: 149–157.
53. Somogyi R, Wen X, Ma W, Barker JL (1995) Developmental kinetics of GAD
family mRNAs parallel neurogenesis in the rat spinal cord. The Journal of
Neuroscience 15: 2575–2591.
54. Santoni D, Pedicini M, Castiglione F (2008) Implementation of a regulatory
gene network to simulate the TH1/2 differentiation in an agent-based model of
hypersensitivity reactions. Bioinformatics 24(11): 1374–1380.
55. Garg A, Di Cara A, Xenarios I, Mendoza L, De Micheli G (2008) Synchronous
vs. Asynchronous Modeling of Gene Regulatory. Networks Bioinformatics
24(17): 1917–1925.
56. Fiucci G, Ravid D, Reich R, Liscovitch M (2002) Caveolin-1 inhibits anchorage-
independent growth, anoikis and invasiveness in MCF-7 human breast cancer
cells. Oncogene 21: 2365–2375.
57. Wiechen K, Diatchenko L, Agoulnik A, Scharff KM, Schober H, et al. (2001)
Caveolin-1 Is Down-Regulated in Human Ovarian Carcinoma and Acts as a
Candidate Tumor Suppressor Gene. Am J Pathol 159(5): 1635–1643.
58. Volanakis JE, Narayana SV (1996) Complement factor D, a novel serine
protease. Protein Science 5(4): 553–564.
59. Wong ET, Jenne DE, Zimmer M, Porter SD, Gilks CB (1999) Changes in
chromatin organization at the neutrophil elastase locus associated with myeloid
cell differentiation. Blood 94(11): 3730–3736.
60. Chen Z, Gordon JR, Zhang X, Xiang J (2002) Analysis of the gene expression
profiles of immature versus mature bone marrow-derived dendritic cells using
DNA arrays. Biochem Biophys Res Commun 290(1): 66–72.
61. Anderson DG, Kowalczykowski SC (1998) Reconstitution of an SOS Response
Pathway: Derepression of Transcription in Response to DNA Breaks. Cell 95:
975–979.
62. Carlini LE, Porter RD (1997) Analysis of ssb mutations in vivo implicates SSB
protein in two distinct pathways of SOS induction and in recombinational DNA
repair. Molecular Microbiology 24(1): 129–139.
63. Blattner FR, Plunkett G, 3rd, Bloch CA, Perna NT, Burland V, et al. (1997) The
complete genome sequence of Escherichia coli K-12. Science 277(5331):
1453–1462.
64. Fan Z, Yuan L, Chatterjee R (2009) Increased Hydrogen Production by Genetic
Engineering of Escherichia coli. PLoS ONE 4(2): e4432. doi:10.1371/
journal.pone.0004432.
65. Yoshida A, Nishimura T, Kawaguchi H, Inui M, Yukawa H (2005) Enhanced
Hydrogen Production from Formic Acid by Formate Hydrogen Lyase-
Overexpressing Escherichia coli Strains. Applied and Environmental Microbi-
ology 71(11): 6762–6768.
66. Yoshida A, Nishimura T, Kawaguchi H, Inui M, Yukawa H (2006) Enhanced
hydrogen production from glucose using ldh-a n dfrd-inactivated Escherichia coli
strains. Applied Microbiology and Biotechnology 73(1): 67–72.
Gene Regulatory Pathways
PLoS ONE | www.plosone.org 11 September 2010 | Volume 5 | Issue 9 | e12475